Therapy News and Research

RSS

Pre-emptive intervention during infancy reduces the likelihood of autism diagnosis

A parent-led therapy that supports the social development of babies displaying early signs of autism has significantly reduced the likelihood of an autism diagnosis being madein early childhood, according to world-first research led by CliniKids atthe Telethon Kids Institute.

21 Sep 2021

Research could lead to new treatment option for breast cancer patients with brain metastases

Breast cancer patients whose cancer spreads to the brain may soon have new treatment options, thanks to research led by CU Cancer Center member Diana Cittelly, PhD.

21 Sep 2021

Researchers reveal a mechanism of SHP2-mediated tumor immunosuppression

Colorectal cancer (CRC), a malignant tumor worldwide consists of microsatellite instability (MSI) and stable (MSS) phenotypes. Although SHP2 is a hopeful target for cancer therapy, its relationship with innate immunosuppression remains elusive. To address that, the authors of this article performed single-cell RNA sequencing to explore the role of SHP2 in all cell types of tumor microenvironment (TME) from murine MC38 xenografts.

21 Sep 2021

NCTN trials gave 14 million years of additional life to cancer patients, analysis finds

Over the past 40 years, people in the U.S. diagnosed with cancer gained 14 million years of additional life thanks to the results of cancer clinical trials conducted by the National Cancer Institute's publicly funded National Clinical Trials Network, according to an analysis to be reported September 20, 2021, at the annual meeting of the European Society for Medical Oncology.

20 Sep 2021

Sunitinib extends progression-free survival in patients with rare neuroendocrine tumor, study shows

The first randomized study in malignant pheochromocytoma and paraganglioma (MPP) has found that sunitinib prolongs progression-free survival (PFS) by more than five months.

20 Sep 2021

Failures and findings from randomized clinical trials in COVID-19 convalescent plasma

Researchers complete an extensive search on previously published studies to understand the efficacy of convalescent plasma in treating COVID-19.

20 Sep 2021

Low-level laser treatment can stimulate hair follicles and hair growth, expert finds

A world-renowned hair loss expert from Chula has discovered that low-level laser treatment can stimulate hair follicles and hair growth.

20 Sep 2021

Role of host gene variants in COVID-19 severity

A new study discusses the importance of common, rare, and intermediate variants of several host genes to the clinical severity of infection with SARS-CoV-2.

20 Sep 2021

Smartphone-based augmented reality app helps tackle the fear of spiders

Researchers from the University of Basel have developed an augmented reality app for smartphones in order to help people reduce their fear of spiders.

20 Sep 2021

Systematic review focuses on women's health associated with menopausal hormone therapy

Treatment with estrogen in menopause is both good and bad for women's health. The picture is complex and the scientific evidence sometimes scanty or only moderately solid, a study shows. University of Gothenburg researchers took part.

20 Sep 2021

Study highlights the usefulness of organoids for basic research into coronaviruses

Researchers from the group of Hans Clevers in collaboration with the group of Bart Haagmans (Erasmus MC) established an organoid biobank to search for the genes that are essential for the spreading of a SARS-CoV2 infection.

20 Sep 2021

Development of a potential pan-variant aerosol to manage COVID-19

Researchers hypothesized that if APN01 could be directly introduced into the airways of an infected person, it could locally neutralize SARS-CoV-2.

19 Sep 2021

A new synthetic multiantigen MVA vaccine COH04S1 effective against SARS-CoV-2

A new study utilized MVA to develop vaccine candidates that were subsequently evaluated in animal models of congenital cytomegalovirus disease.

19 Sep 2021

R37 MERIT Award supports innovative ovarian cancer research

One of the most impactful advancements during the past decade in treating ovarian cancer is the use of PARP inhibitors (short for poly adenosine diphosphate-ribose polymerase). PARP inhibitors are a type of cancer drug that blocks the PARP enzyme from helping to repair DNA damage in cancer cells.

18 Sep 2021

Therapy News and Research

Pre-emptive intervention during infancy reduces the likelihood of autism diagnosis

Research could lead to new treatment option for breast cancer patients with brain metastases

Researchers reveal a mechanism of SHP2-mediated tumor immunosuppression

NCTN trials gave 14 million years of additional life to cancer patients, analysis finds

Sunitinib extends progression-free survival in patients with rare neuroendocrine tumor, study shows

Failures and findings from randomized clinical trials in COVID-19 convalescent plasma

Low-level laser treatment can stimulate hair follicles and hair growth, expert finds

Role of host gene variants in COVID-19 severity

Smartphone-based augmented reality app helps tackle the fear of spiders

Systematic review focuses on women's health associated with menopausal hormone therapy

Study highlights the usefulness of organoids for basic research into coronaviruses

Development of a potential pan-variant aerosol to manage COVID-19

A new synthetic multiantigen MVA vaccine COH04S1 effective against SARS-CoV-2

R37 MERIT Award supports innovative ovarian cancer research

Pairing bacteriophages with antibiotics to fight drug-resistant pathogens

Novel drug combinations improve progression-free survival for patients with advanced NSCLC

Research reveals a possible new treatment approach for pediatric rhabdomyosarcoma

Study of internet-delivered trauma-focused CBT shows promising results

Humoral and cellular response to COVID-19 vaccines in patients with IBD

mAb treatment can rapidly select for SARS-CoV-2 resistance, suggests study

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News